vindesine sulfate

Vindesine Vinblastine derivative with antineoplastic activity against acute leukemia, lung cancer, carcinoma of the breast, squamous cell carcinoma of the esophagus, head, and neck, and Hodgkin's and non-Hodgkin's lymphomas. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols.

Molecular Formula: C₄₉H₇₁N₅O₁₇S

InChI: InChI=1/C43H55N5O7.C6H14O6.H2O4S/c1-6-39(52)16-13-25-23-47(24-39)19-14-27-26-11-8-9-12-30(26)45-33(27)42(25,38(51)55-5)29-21-28-31(22-32(29)54-4)46(3)35-41(28)17-20-48-18-10-15-40(7-2,34(41)48)36(49)43(35,53)37(44)50;7-1-3(9)5(11)6(12)4(10)2-8;1-5(2,3)4/h8-12,15,21-22,25,34-36,45,49,52-53H,6-7,13-14,16-20,23-24H2,1-5H3,(H2,44,50);3-12H,1-2H2;(H2,1,2,3,4)/t25-,34-,35+,36+,39-,40+,41+,42-,43-;;/m0../s1/f/h44H2;;1-2H

InChIKey: InChIKey=GKDANULDUQHREB-JXIYFCQNDZ
SMILES: CCC1(CCC2CN(C1)CCC3=C(C2(C4=C(C=C5C(=C4)C67CCN8C6C(C=CC8)(C(C(C7N5C)(C(=O)N)O)O)CC)OC)C(=O)OC)NC9=CC=CC=C39)O.C(C(C(C(C(CO)O)O)O)O)O.OS(=O)(=O)O

Names:
    NSC245467
    vindesine sulfate
    59917-39-4

Registries:
    PubChem CID 5458470
    PubChem ID 8140698